HEMISPHERX BIOPHARMA INC's ticker is HEB and the CUSIP is 42366C301. A total of 21 filers reported holding HEMISPHERX BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $11,000 | -57.7% | 74,832 | -50.0% | 0.00% | – |
| Q4 2018 | $26,000 | +52.9% | 149,664 | +100.0% | 0.00% | – |
| Q3 2018 | $17,000 | -26.1% | 74,832 | 0.0% | 0.00% | – |
| Q2 2018 | $23,000 | -20.7% | 74,832 | 0.0% | 0.00% | – |
| Q1 2018 | $29,000 | +16.0% | 74,832 | 0.0% | 0.00% | – |
| Q4 2017 | $25,000 | +4.2% | 74,832 | 0.0% | 0.00% | – |
| Q3 2017 | $24,000 | -35.1% | 74,832 | 0.0% | 0.00% | – |
| Q2 2017 | $37,000 | -7.5% | 74,832 | 0.0% | 0.00% | – |
| Q1 2017 | $40,000 | -21.6% | 74,832 | 0.0% | 0.00% | – |
| Q4 2016 | $51,000 | -45.2% | 74,832 | +0.0% | 0.00% | – |
| Q3 2016 | $93,000 | – | 74,831 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,938,374 | $620,000 | 0.10% |
| Occidental Asset Management, LLC | 15,834 | $5,000 | 0.00% |
| Waldron Private Wealth LLC | 11,000 | $3,000 | 0.00% |
| VANGUARD GROUP INC | 467,574 | $150,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 1,080 | $0 | 0.00% |
| UBS Group AG | 20,658 | $7,000 | 0.00% |
| Advisor Group, Inc. | 250 | $0 | 0.00% |
| Jacobi Capital Management LLC | 318 | $0 | 0.00% |
| HUNTINGTON NATIONAL BANK | 2,501 | $0 | 0.00% |
| CITY HOLDING CO | 417 | $0 | 0.00% |